Detalhe da pesquisa
1.
An ACAT inhibitor suppresses SARS-CoV-2 replication and boosts antiviral T cell activity.
PLoS Pathog
; 19(5): e1011323, 2023 05.
Artigo
Inglês
| MEDLINE | ID: mdl-37134108
2.
Potential Anti-Mpox Virus Activity of Atovaquone, Mefloquine, and Molnupiravir, and Their Potential Use as Treatments.
J Infect Dis
; 228(5): 591-603, 2023 08 31.
Artigo
Inglês
| MEDLINE | ID: mdl-36892247
3.
Should a viral genome stay in the host cell or leave? A quantitative dynamics study of how hepatitis C virus deals with this dilemma.
PLoS Biol
; 18(7): e3000562, 2020 07.
Artigo
Inglês
| MEDLINE | ID: mdl-32730280
4.
Identification of IMP Dehydrogenase as a Potential Target for Anti-Mpox Virus Agents.
Microbiol Spectr
; 11(4): e0056623, 2023 08 17.
Artigo
Inglês
| MEDLINE | ID: mdl-37409948
5.
Different efficacies of neutralizing antibodies and antiviral drugs on SARS-CoV-2 Omicron subvariants, BA.1 and BA.2.
Antiviral Res
; 205: 105372, 2022 09.
Artigo
Inglês
| MEDLINE | ID: mdl-35798223
6.
Mefloquine, a Potent Anti-severe Acute Respiratory Syndrome-Related Coronavirus 2 (SARS-CoV-2) Drug as an Entry Inhibitor in vitro.
Front Microbiol
; 12: 651403, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-33995308
7.
Potential anti-COVID-19 agents, cepharanthine and nelfinavir, and their usage for combination treatment.
iScience
; 24(4): 102367, 2021 Apr 23.
Artigo
Inglês
| MEDLINE | ID: mdl-33817567